Related Experiment Video
Updated: Feb 20, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
[Risk factors for atherosclerosis in obese children aged 6-12 years]
Alicja Karney1, Hanna Brągoszewska2, Leszek Soluch3
1Oddział Hospitalizacji Jednego Dnia, Instytut Matki i Dziecka, Warszawa, Polska.
Insights
Childhood obesity is linked to early signs of atherosclerosis, with obese children showing higher lipid levels and increased intima-media thickness (IMT). Early detection through noninvasive methods is crucial for managing cardiovascular risks.
Area of Science:
- Pediatric Endocrinology
- Cardiovascular Health
- Metabolic Disorders
Background:
- Childhood obesity is a growing concern, contributing to metabolic and structural vascular changes.
- These changes increase the risk of developing cardiovascular diseases and type 2 diabetes in children.
- Early identification of risk factors for atherosclerosis in obese children is critical.
Purpose of the Study:
- To assess risk factors for atherosclerosis in obese children.
- To compare vascular and metabolic markers between obese children and a healthy control group.
- To evaluate the role of family history and lifestyle factors in childhood obesity-related vascular changes.
Main Methods:
- Study included 75 obese children (BMI >97th percentile, aged 6-12) and 36 healthy controls (BMI 75-90, aged 5-10).
- Evaluated family history of obesity, cardiovascular disease (CVD), and dyslipidemia.
- Measured BMI, waist circumference, lipid profiles (cholesterol, LDL, HDL, triglycerides), insulin, and intima-media thickness (IMT) via ultrasound.
Main Results:
- Obese children had a significantly higher prevalence of positive family history for obesity (82.6%) and CVD/dyslipidemia (72%) compared to controls.
- Obese children exhibited higher mean waist circumference (72.7 cm vs. 59.9 cm), elevated lipid levels, and nearly double the insulin levels.
- Mean IMT was significantly higher in obese children (0.36-0.37 mm) than in controls (0.32 mm), indicating early atherosclerotic changes.
Conclusions:
- Obesity and dyslipidemia are more prevalent in children with a familial predisposition to obesity and CVD.
- Significantly higher IMT in obese children suggests early-onset carotid atherosclerosis, detectable by ultrasound.
- Increased insulin levels in obese children may indicate insulin resistance, and parental knowledge gaps regarding obesity's long-term effects persist.
Abstract:
Obesity in children causes metabolic and structural changes in blood vessels which lead to the development of cardiovascular diseases and type 2 diabetes.
Aim:
The aim of the study was to assess the risk factors for atherosclerosis in obese children studied in the One-Day Hospitalization Department of the Institute of Mother and Child.
Material And Methods:
The study included 75 children aged 6-12 years (36 boys, 39 girls) with aBMI>97th percentile. The control group consisted of 36 children aged 5-10 years (18 boys, 18 girls) with a BMI of 75-90. Analysis was conducted of family history regarding obesity, CVD, dyslipidemia. The children's examination consisted of: BMI, waist circumference, cholesterol, LDL, HDL, triglycerides, and insulin. Both groups had their IMT (left and right) examined with ultrasound.
Results:
In the study group 82.6% of the obese children had a positive family history of obesity and 72% of CVD and dyslipidemia. Regarding the children from the control group, 34.2% had a family history of obesity and 36.8 of CVD and dyslipidemia. The mean waist circumference in the obese children was 72.7 cm, while in the control group it was 59.9 (<0.001). The mean levels of lipids were higher in obese children (<0.001). The insulin level was almost twice as high as in the control group (±8.47 SD; <0.003). The mean IMT in obese patients was 0.36 mm; ±0.059 SD (right side) and 0.37 mm; ±0.033 SD (left side), while in the control group it was 0.32 mm; ±0.087 SD (right side) and 0.32 mm, ±0.082 SD (left side). The differences between the two groups were statistically significant. A positive correlation between waist circumference and insulin level was found (<0.003).
Conclusions:
Obesity and dyslipidemia are more common among children with familial obesity and CVD. Dyslipidemia is statistically more widespread among obese children. IMT is significantly higher in obese children compared with the control group, suggesting that changes in the structure of carotid atherosclerosis may occur in obese children in early childhood. This can be diagnosed using the noninvasive IMT method measured with ultrasound. Children with obesity, especially visceral, have higher levels of insulin, which may contribute to insulin resistance. Parents lack sufficient knowledge about the effects of childhood obesity and its effects on atherosclerosis and cardiovascular diseases.
Results:
In the study group 82.6% of the obese children had a positive family history of obesity and 72% of CVD and dyslipidemia. Regarding the children from the control group, 34.2% had a family history of obesity and 36.8 of CVD and dyslipidemia. The mean waist circumference in the obese children was 72.7 cm, while in the control group it was 59.9 (<0.001). The mean levels of lipids were higher in obese children (<0.003).
Conclusions:
Obesity and dyslipidemia are more common among children with familial obesity and CVD. Dyslipidemia is statistically more widespread among obese children. IMT is significantly higher in obese children compared with the control group, suggesting that changes in the structure of carotid atherosclerosis may occur in obese children in early childhood. This can be diagnosed using the noninvasive IMT method measured with ultrasound. Children with obesity, especially visceral, have higher levels of insulin, which may contribute to insulin resistance. Parents lack sufficient knowledge about the effects of childhood obesity and its effects on atherosclerosis and cardiovascular diseases.
Related Concept Videos
Obesity
Atherosclerosis I: Introduction
Coronary Artery Disease I: Introduction
Atherosclerosis III: Management
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

